Cargando…

CDK4 Amplification in Esophageal Squamous Cell Carcinoma Associated With Better Patient Outcome

In the present study, we aimed to investigate the clinical and prognostic values of CDK4 amplification and improve the risk stratification in patients with esophageal squamous cell carcinoma. CDK4 amplification was analyzed by fluorescence in situ hybridization using tissue microarray consisting of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Jie, Wang, Xiang, Zhang, Xue, Chen, Weijie, Luan, Lijuan, Song, Qi, Wang, Hao, Liu, Jia, Xu, Lei, Xu, Yifan, Shen, Licheng, Tan, Lijie, Jiang, Dongxian, Su, Jieakesu, Hou, Yingyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116700/ https://www.ncbi.nlm.nih.gov/pubmed/33995474 http://dx.doi.org/10.3389/fgene.2021.616110

Ejemplares similares

The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma
por: Jiang, Dongxian, et al.
Publicado: (2015)

SOX2 amplification and chromosome 3 gain significantly impact prognosis in esophageal squamous cell carcinoma
por: Wang, Xin, et al.
Publicado: (2021)

Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients
por: Wang, Yanqiu, et al.
Publicado: (2019)

PMS2 Expression With Combination of PD-L1 and TILs for Predicting Survival of Esophageal Squamous Cell Carcinoma
por: Jiang, Dongxian, et al.
Publicado: (2022)

Distribution of residual tumors in esophageal squamous cell carcinoma after neoadjuvant PD-1 blockade combined with chemotherapy
por: Jiang, Dongxian, et al.
Publicado: (2023)

The prognostic significance of MCL1 copy number gain in esophageal squamous cell carcinoma
por: Xu, Chen, et al.
Publicado: (2017)

HER2 Positivity Is Affected by the Papillary Structure and Has a Bidirectional Prognostic Value for Gallbladder Carcinoma
por: Chen, Lingli, et al.
Publicado: (2022)

Tumour infiltrating lymphocytes correlate with improved survival in patients with esophageal squamous cell carcinoma
por: Jiang, Dongxian, et al.
Publicado: (2017)

Independent prognostic role of PD-L1 expression in patients with esophageal squamous cell carcinoma
por: Jiang, Dongxian, et al.
Publicado: (2016)

Pharmacological Inhibition of PP2A Overcomes Nab-Paclitaxel Resistance by Downregulating MCL1 in Esophageal Squamous Cell Carcinoma (ESCC)
por: Song, Qi, et al.
Publicado: (2021)

Comparison of the prognostic difference between ypTNM and equivalent pTNM stages in esophageal squamous cell carcinoma based on the 8th edition of AJCC classification
por: Jiang, Dongxian, et al.
Publicado: (2020)

Unclassified mesenchymal sarcoma with NTRK1-KHDRBS1 gene fusion: a case report of long-term tumor-free survival with crizotinib treatment
por: Chen, Weijie, et al.
Publicado: (2021)

Chromosomal and Genomic Variations in Esophageal Squamous Cell Carcinoma: A Review of Technologies, Applications, and Prospections
por: Song, Qi, et al.
Publicado: (2017)

Prognostic value of visual residual tumour cells (VRTC) for patients with esophageal squamous cell carcinomas after neoadjuvant therapy followed by surgery
por: Wang, Xingxing, et al.
Publicado: (2021)

High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients
por: Song, Qi, et al.
Publicado: (2017)

Diagnostic application of PIK3CA mutation analysis in Chinese esophageal cancer patients
por: Ming, Zizhen, et al.
Publicado: (2014)

An alternative high output tissue microarray technique
por: Shi, Yuan, et al.
Publicado: (2013)

Late stage gastric cancer patients with extra gained HER2 positivity by dual block assessment may not show compromised efficacy to trastuzumab treatment
por: Xu, Chen, et al.
Publicado: (2019)

The role of GPR110 in lung cancer progression
por: Ma, Benting, et al.
Publicado: (2020)

DASES: a database of alternative splicing for esophageal squamous cell carcinoma
por: Chen, Yilong, et al.
Publicado: (2023)

Risk Stratification and Validation of Eleven Autophagy-Related lncRNAs for Esophageal Squamous Cell Carcinoma
por: Zhao, Xu, et al.
Publicado: (2022)

The efficacy of additional surgical resection after endoscopic resection in pT1b esophageal squamous cell carcinoma: A multi-institutional retrospective study in China
por: Xue, Xuemin, et al.
Publicado: (2022)

Tumor containing fragment number influences immunohistochemistry positive rate of HER2 in biopsy specimens of gastric cancer
por: Xu, Chen, et al.
Publicado: (2017)

Drug repositioning for esophageal squamous cell carcinoma
por: Bennett, Adam N., et al.
Publicado: (2022)

Identification of Tumor Antigens and Immune Subtypes of Esophageal Squamous Cell Carcinoma for mRNA Vaccine Development
por: Lu, Tong, et al.
Publicado: (2022)

Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type
por: Xu, Chen, et al.
Publicado: (2017)

Development and Validation of the Predictive Model for Esophageal Squamous Cell Carcinoma Differentiation Degree
por: Wang, Yanfeng, et al.
Publicado: (2020)

Ferroptosis patterns and tumor microenvironment infiltration characterization in esophageal squamous cell cancer
por: Zhang, Lu-Lu, et al.
Publicado: (2022)

The prognostic role of c-MYC amplification in schistosomiasis-associated colorectal cancer
por: Pan, Weiyu, et al.
Publicado: (2020)

Genetic variant of ADH1C for predicting survival in esophageal squamous cell cancer patients who underwent postoperative radiotherapy
por: Xu, Xin, et al.
Publicado: (2022)

High Expression of Citron Kinase Contributes to the Development of Esophageal Squamous Cell Carcinoma
por: Lu, Wenfeng, et al.
Publicado: (2021)

A three-gene signature and clinical outcome in esophageal squamous cell carcinoma
por: Sun, Ling-Ling, et al.
Publicado: (2015)

Anti-POSTN and Anti-TIMP1 Autoantibodies as Diagnostic Markers in Esophageal Squamous Cell Carcinoma
por: Xie, Weihong, et al.
Publicado: (2022)

Proteomic analysis reveals key differences between squamous cell carcinomas and adenocarcinomas across multiple tissues
por: Song, Qi, et al.
Publicado: (2022)

Identification of Candidate Therapeutic Genes for More Precise Treatment of Esophageal Squamous Cell Carcinoma and Adenocarcinoma
por: Polewko-Klim, Aneta, et al.
Publicado: (2022)

Identification of Key Genes and Pathways Associated With Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis
por: Shen, Zhimin, et al.
Publicado: (2021)

Prognostic Value of SPOCD1 in Esophageal Squamous Cell Carcinoma: A Comprehensive Study Based on Bioinformatics and Validation
por: Lin, Zhizhong, et al.
Publicado: (2022)

Identification of clinical prognostic features of esophageal cancer based on m6A regulators
por: Wang, Huimei, et al.
Publicado: (2022)

The Clinical Significance and Potential Molecular Mechanism of PTTG1 in Esophageal Squamous Cell Carcinoma
por: Chen, Shang-Wei, et al.
Publicado: (2021)

Long Read Single-Molecule Real-Time Sequencing Elucidates Transcriptome-Wide Heterogeneity and Complexity in Esophageal Squamous Cells
por: Cheng, Yin-Wei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gk0790dhfvpi2ek6g63asvg3td